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Untangling the Relationship Between Diet and Visceral Fat Mass Through Blood Metabolomics 
and Gut Microbiome Profiling 
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Abstract 1 
BACKGROUND/OBJECTIVES: Higher visceral fat mass (VFM) is associated with an increased 2 
risk for developing cardio-metabolic diseases. The mechanisms by which an unhealthy diet pattern 3 
may influence VF development has yet to be examined through cutting-edge multi-omic methods.  4 
Therefore, our objective was to examine the dietary influences on VFM and identify gut microbiome 5 
and metabolite profiles that link food intakes to VFM.  6 
SUBJECTS/METHODS: In 2218 twins with VFM, food intake and metabolomics data available we 7 
identified food intakes most strongly associated with VFM in 50% of the sample, then constructed 8 
and tested the ‘VFM diet score’ in the remainder of the sample. Using linear regression (adjusted for 9 
covariates, including BMI and total fat mass) we investigated associations between the VFM diet 10 
score, the blood metabolomics profile and the faecal microbiome (n=889), and confirmed these 11 
associations with VFM. We replicated top findings in monozygotic (MZ) twins discordant (≥1 SD 12 
apart) for VFM, matched for age, sex and the baseline genetic sequence. 13 
RESULTS:  Four metabolites were associated with the VFM diet score and VFM: hippurate, alpha-14 
hydroxyisovalerate, bilirubin (Z,Z) and butyrylcarnitine. We replicated associations between VFM 15 
and the diet score (Beta[SE]: 0.281[0.091]; P=0.002), butyrylcarnitine (0.199[0.087]; P=0.023) and 16 
hippurate (-0.297[0.095]; P=0.002) in VFM-discordant MZ twins. We identified a single species, 17 
Eubacterium dolichum to be associated with the VFM diet score (0.042[0.011], P=8.47x10
-5
), VFM 18 
(0.057[0.019], P=2.73x10
-3
) and hippurate (-0.075[0.032], P=0.021). Moreover, higher blood 19 
hippurate was associated with elevated adipose tissue expression neuroglobin, with roles in cellular 20 
oxygen homeostasis (0.016[0.004], P=9.82x10
-6
). 21 
CONCLUSION: We linked a dietary VFM score and VFM to Eubacterium dolichum and four 22 
metabolites in the blood. In particular, the relationship between hippurate, a metabolite derived from 23 
microbial metabolism of dietary polyphenols, and reduced VFM, the microbiome and increased 24 
adipose tissue expression of neuroglobin provides potential mechanistic insight into the influence of 25 
diet on VFM.  26 
  27 
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Introduction 28 
Increased visceral fat (VF) is a strong risk factor for cardio-metabolic diseases. Observational studies 29 
have found that intakes of fruit
1
, dairy
1
 and nutrients
2
, and whole grains
3
, and fibre
2, 4
 are protective, 30 
whereas intakes of fried foods and fat
1, 5
, alcohol, red and processed meat
1
 and related nutrients
2
, 31 
sugar-sweetened beverages
1, 5-7
 and refined grains
1, 3
 and high glycaemic index foods
8, 9
 are associated 32 
with higher levels of VF mass (VFM) or waist circumference (WC).  33 
Over the past decade, studies on dietary patterns have emerged to examine the impact of the 34 
whole diet on metabolic health. In a recent study, authors created a protective diet score using self-35 
reported intakes of favorable and unfavourable foods to investigate gene X diet interactions in obesity 36 
in 68,317 subjects of European ancestry
10
. In another study of 48,631 European men and women, 37 
Angquist et al.
1
 created a summary score combining intakes of all food groups associated with 38 
changes in WC over a median of 5.5 years. These large studies have confirmed the utility of this 39 
approach to studying VF interactions with diet, though the method has yet to be applied to omic data.  40 
Metabolomics is being used to bridge the knowledge gap between diet and its effect on 41 
metabolic diseases. We recently showed that blood metabolites related to VFM link the impact of 42 
VFM on T2D, insulin resistance and blood pressure
11
. Moreover, we found reported food intakes to be 43 
associated with 106 different metabolites
12
, establishing the central role of food intake on metabolic 44 
traits. However, the metabolomics profile of a metabolically unhealthy diet has not been thoroughly 45 
characterised and those metabolites linking diet to VFM development been distinguished.  46 
Emerging evidence suggests a role for the intestinal microbiota in VF development by 47 
interacting with dietary components and contributing to the metabolomics profile
13
. Early studies 48 
using rodents fed high-fat (HF) diets, have shown HF feeding to increase Firmicutes and decrease 49 
Bacteriodetes
14
,  reduce the class Clostridia
15
, and increase sulfidogenic bactera
16
. Through 50 
modulating the gut microbiome profile, polyphenols from cranberry
17
 and pomegranate
18
, resveratrol
18
 51 
and gluco-oligosaccharide
19
 have shown to be protective of obesity in HF feeding.  52 
The aims of the present study were to identify foods most strongly associated with VFM in a 53 
population of UK twins, to develop and test a predictive dietary VFM-risk score using these food 54 
intakes, and to link the blood metabolomics and gut microbiome profiles of the score to VFM.   55 
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Materials and Methods 56 
Twins enrolled in the TwinsUK registry, a register of UK adult twins
20
, were included in the study. 57 
Twins were recruited throughout the UK primarily by media campaigns without selecting for specific 58 
diseases or traits. Food intakes were determined by a 131-item validated Food Frequency 59 
Questionnaire (FFQ)
21
 between 1995 and 2001, in 2007 and 2014 to 2015. Quality control, subject 60 
exclusion criteria and methods for nutrient determination from FFQ data have been described 61 
previously
22
. Food frequencies were combined into 20 different food types prior to analysis 62 
(Supplementary Table S1). Other relevant phenotypic data include BMI and zygosity which were 63 
determined by methods outlined previously
20. The study was approved by the St. Thomas’ Hospital 64 
Research Ethics committee and all subjects provided informed written consent. 65 
Visceral Fat Mass 66 
Visceral fat mass (VFM; g) was determined in 3457 female and 142 male twins by DXA (Dual-67 
Energy X-ray Absorptiometry; Hologic QDR; Hologic, Inc., Waltham, MA, USA) whole-body 68 
scanning (supine) at a clinical visit by a trained research nurse. The QDR System Software Version 69 
12.6 was used to analyse the scans. VFM was calculated from one cross-section of the whole body at 70 
L4-L5, the typical location of a CT slice. Subjects were excluded from the analysis if their VFM was 71 
4 SD outside of the mean VFM. VFM did not follow a normal distribution and was normalised using 72 
a rank-based inverse-normalisation.  73 
Metabolomic profiling 74 
Non-targeted mass spectroscopy-based metabolomic profiling was conducted by the metabolomics 75 
provider Metabolon, Inc. (Durham, NC) on 6056 fasting blood samples, as described previously
23, 24
.  76 
During the twin’s annual visit to St. Thomas’ Hospital fasted blood samples were collected by a 77 
trained research nurse and stored at -80°C until further metabolomic processing. The Metabolon 78 
platform identified 292 structurally named biochemicals categorized into the following broad 79 
categories: amino acids, carbohydrates, vitamins, lipids, nucleotides, peptides, and xenobiotics. 80 
Quality control on the metabolomics dataset was performed as previously described
23, 24
. Raw data 81 
were median-normalised by dividing metabolite concentrations by the day median of that metabolite 82 
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and then inverse-normalised. For the metabolomics analysis we included 2218 male (n=4) and female 83 
(n=2214) twins who had metabolomics profiling, BMI and VFM data available within and including ± 84 
5 years of FFQ completion. 85 
Gut microbiome profiles 86 
Faecal samples were collected at home by the twins and stored in the refrigerator for 2 days or less 87 
prior to their annual clinical visit at St. Thomas’ Hospital. Samples were stored at -80°C until further 88 
processing. Bacterial profiles were generated using 16S rRNA gene sequencing. Microbial DNA 89 
extracted, amplified, sequenced and processed, as part of a prior study
25
 (see reference for details), 90 
with an additional ∼1000 samples collected and processed under the same protocols. Sequencing 91 
reads were summarized as operational taxonomic units (OTUs) at 97% sequence similarity. This was 92 
carried out using UCLUST open-reference clustering against Greengenes v13_5 reference within 93 
QIIME 1.7.0, 6.2 % of the total sequences did not cluster to the reference and were excluded
25
. 94 
OTUs that were observed in fewer than 25 % of individuals were not considered for further 95 
study. Of 9,840 OTUs (after removing singletons) 16 % passed this threshold, resulting in a final set 96 
of 2,118 OTUs. All OTU counts (including those in less than 25% of individuals) were collapsed into 97 
taxonomies at the family (124 variables), genus (283 variables) and species (153 variables) levels 98 
where only fully classified taxa were considered within each level. Alpha-diversity was measured 99 
using Shannon’s phylogenetic diversity26 (also using QIIME) after rarefaction of the complete OTU 100 
table to 10000 reads per sample. OTUs were adjusted for technical covariates including sequencing 101 
run and number of sequences in each sample using linear regression. The data was normalized using 102 
rank-based inverse normalization. For the current study we analyzed a subsample of the FFQ, VFM 103 
and metabolomics sample for which we also had fecal microbiome profiling (n=889). 104 
Muther expression data  105 
Gene expression of abdominal fat samples in 825 individuals were analysed with the Illumina Human 106 
HT-12 V3 for the Muther study, as described previously
27
. 586 individuals were analyzed for 107 
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expression association with the top metabolite using a random intercept linear regression including 108 
age, BMI, metabolite batch, expression batch, and family relatedness. 109 
Statistical analysis 110 
Statistical analysis was carried out using Stata version 12. 111 
Figure 1 summarizes the protocol and the specific details of data analysis are as follows: 112 
VFM food type associations and diet score formation and heritability 113 
To determine significant associations between food intakes and VFM, we first randomly allocated 114 
twins to two groups (the training and test groups) ensuring co-twins assigned to the same group. In the 115 
training group (n=1109) a linear regression was performed for each of the 20 food groups (predictor 116 
variable) adjusted for covariates (total fat mass, age, sex, height
2
, family relatedness, DEXA batch) 117 
with VFM (residual adjusted for BMI) as the response variable. Associations were considered 118 
significant if they passed the Bonferroni cut-off for multiple testing (P<2.50x10
-3 
= [0.05/20 food 119 
groups]). Food groups significantly associated with VFM were included in the final score. To 120 
calculate the score, reported consumption frequencies of these food groups were quartile ranked and 121 
the quartiles assigned a score of 0 to 3 according to direction of the association (i.e. positive 122 
association: Q1=0, Q2=1, Q3=2, Q4=3; negative association: Q1=3, Q2=2, Q3=1, Q4=0). Therefore a 123 
higher VFM diet score is associated with a poorer diet quality. Following score assignment, scores for 124 
all variables were summed with the final score ranging from 0 to 15. Heritability of the VFM diet 125 
score was determined using linear structural equation modelling in Mx
28, 29
, details can be found in 126 
Supplementary Text S1.  127 
Binary classification test 128 
In the test group (n = 1109) the VFM diet score was first calculated as described above and then fitted 129 
into a logistic regression model adjusted for covariates (total fat mass, age, sex, height
2
, family 130 
relatedness, DEXA batch, and BMI category [1: <18.5 kg/m
2; 2: ≥18.5-24.9 kg/m2; 3: ≥25-29.9 131 
kg/m
2; 4: ≥30 kg/m2]) with the lower tertile of VFM assigned a negative outcome (0; n = 369), and the 132 
top (high VFM) tertile of VFM considered a positive outcome (1; n = 370). A binary classification 133 
test was then conducted to evaluate the predictive ability of the VFM diet score. The ability of the 134 
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VFM diet score to correctly classify subjects with high VFM (sensitivity; true positive rate) and 135 
correctly classify subjects with low VFM (specificity; true negative rate) of the model was predicted 136 
and the receiver operating characteristic curve (ROC) generated by plotting the true positive rate 137 
against the false positive rate at multiple threshold settings.  138 
 139 
VFM diet score and VFM associations with metabolomics and the microbiome 140 
Details of the statistical analysis for the associations between the VFM diet score and VFM with 141 
blood metabolomics and microbiome taxa can be found in Supplementary Text S2.  142 
 143 
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Results 144 
VFM food group associations 145 
The characteristics of the study population can be found in Supplementary Table S3.  146 
We identified 5 significant food type associations with VFM in the training dataset, including:  147 
Fruits (-0.005[0.001]; P=1.95x10
-5
), red, processed meat and eggs (0.016[0.005]; P=3.94x10
-4
), 148 
fermented dairy products (-0.011[0.004]; P=1.14x10
-3
), fried and fast foods (0.015[0.005]; 149 
P=1.18x10
-3
), and whole grain products (-0.008[0.002]; P=1.27x10
-3
). We next generated and 150 
evaluated the VFM diet score in the test group. The sensitivity of the VFM diet score was 93.72%, the 151 
specificity was 92.70% and overall 93.21% of subjects were classified into the correct VFM tertile. 152 
Figure 2 shows the ROC curve (AUC: 0.9841 [95% CI: 0.9772; 0.9911]). The association between 153 
the diet score and VFM was significant in VFM-discordant MZ twins (0.281[0.091]; P=0.002). The 154 
diet score was strongly heritable (h
2
>40%) at 44% (95% CI: 37%, 50%) (Supplementary Table S4). 155 
The nutrient profile of the VFM diet score is shown in Figure 3 (Supplementary Table S5).  156 
VFM diet score metabolomics associations  157 
We identified 30 metabolites significantly associated (P<1.71x10
-4
) with the VFM diet score after 158 
adjusting for covariates and multiple testing (Supplementary Table S6).  159 
Following an adjustment for intakes of other foods (Supplementary Table S6) all 160 
associations between metabolites and the VFM diet score remained strong (P<0.01) though 6 no 161 
longer passed adjustment for multiple testing, suggesting intakes of other foods may be important for 162 
these metabolites.    163 
Metabolites associated with the VFM diet score and food groups independently 164 
Eighteen metabolites were significantly (P<3.33x10
-4
 (0.05/[5 food groups x 30 metabolites])) 165 
associated with the food groups forming the VFM diet score following backward regression with all 166 
food groups (Supplementary Table S6). Notably, fruit intake was significantly associated with 11 167 
metabolites. Whole grain intake was significantly associated with 5 metabolites, red, processed meat, 168 
and eggs with 3 metabolites, and fried and fast food intakes with 2 metabolites.  169 
Metabolites associated to both the VFM diet and VFM 170 
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Following a backward stepwise linear regression including all 30 metabolites, nine 171 
metabolites (accounting for 14% of the variance) remained significantly associated with the VFM diet 172 
score (Table 1). After adjusting for multiple testing (P<5.56x10
-3
), four of them were significantly 173 
associated with VFM independently of diet.   174 
Reduced hippurate and bilirubin (Z,Z), and increased alpha-hydroxyisovalerate and 175 
butyrylcarnitine were all associated with increased VFM diet scores and VFM independently of the 176 
VFM diet and total body fat (Table 1). Associations between VFM and butyrylcarnitine 177 
(0.199[0.087]; P=0.023) and hippurate (-0.297[0.095]; P=0.002) were significant in VFM-discordant 178 
MZ twins (Figure 4; Supplementary Table S7). The metabolites explained on average 18.5% of the 179 
variance (range: 13.5%-28.9%) in the association between the VFM diet score and VFM (Table 1).  180 
VFM diet score microbiome associations 181 
Increased scores on the VFM diet were associated with reduced gut microbiome diversity (Shannon 182 
Index; -0.025[0.009], P=6.26x10
-3
), this association remained significant but was attenuated following 183 
adjustment for VFM (-0.020[0.010], P=0.035).  184 
Eight OTUs (Supplementary Table S8) and six taxa (Table 2) were significantly associated 185 
with the VFM diet score. The associations remained nominally significant (P<0.05) following an 186 
adjustment for intakes of other foods (Table 2). 187 
Microbiome taxa associated to both the VFM diet and VFM 188 
Increased abundance of the species Eubacterium dolichum (0.057[0.019], P=2.73x10
-3
) was 189 
significantly associated with higher VFM and a Bifidobacterium OTU (OTU ID: 4426298; -190 
0.046[0.016], P=0.005) with lower VFM, both independently of the VFM diet score. We found that 191 
16.4% of the effect of the VFM diet score on VFM (r
2
x= 0.0238) was mediated by E. dolichum (r
2
xy= 192 
0.0199) and 17.2% by the Bifidobacterium OTU.  193 
Eubacterium dolichum and hippurate associated with both VFM and VFM diet 194 
We tested associations with those 4 metabolites associated with both VFM and the VFM diet 195 
for their association with E. dolichum and the Bifidobacterium OTU. We identified increased 196 
abundances of E. dolichum to be associated with significantly lower levels of hippurate at the nominal 197 
level (P<0.05) independently of VFM, the VFM diet score, Shannon Index and covariates (-198 
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0.075[0.032], P=0.021). We further determined that 36.9% of the effect of Eubacterium dolichum on 199 
VFM (r
2
x= 0.0065) was mediated by hippurate (r
2
xy= 0.0041) after adjusting for diet and covariates.  200 
Hippurate association with adipose tissue transcriptome 201 
 We found increased levels of hippurate neuroglobin in the greater twin population to be 202 
associated with elevated adipose tissue expression of neuroglobin, a member of the vertebrate globin 203 
family involved in cellular oxygen homeostasis (0.016[0.004], P=9.82x10
-6
). 204 
 205 
 206 
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Discussion 207 
In this study, using a newly developed dietary VFM risk score, authenticated in the test population, 208 
we have characterised for the first time the blood metabolomics profile of a dietary pattern predictive 209 
of VFM and have identified a specific gut bacterial species associated with this pattern and VFM after 210 
adjusting for a range of confounders. Our novel data have highlighted the species E. dolichum in the 211 
gut and hippurate in blood may link diet to VFM. 212 
Our score was highly predictive of VFM in our population (including in MZ twins discordant 213 
for VFM), which allowed us to investigate the impact of diet on VFM development using 214 
metabolomics and microbiome methods. Four metabolites were associated with both the VFM diet 215 
score and VFM (independently of diet). They included reduced hippurate and bilirubin (Z,Z), and 216 
increased alpha-hydroxyisovalerate and butyrylcarnitine with increasing VFM diet scores and VFM. 217 
Alpha-hydroxyisovalerate and butyrylcarnitine are metabolites of BCAA catabolism and fatty acid 218 
metabolism that have been found to be elevated in obese children
30
 and adults
31
. Moreover alpha-219 
hydroxyisovalerate has been identified as an important predictor of insulin resistance and glucose 220 
intolerance
32, 33
. Both metabolites were associated with higher intakes of red and processed meats and 221 
eggs. Animal derived fats and protein have not been specifically linked to disrupted BCAA 222 
metabolism in humans though under HF feeding in mice the addition of BCAA exacerbates insulin 223 
resistance through stimulating the mTOR kinase pathway
34
.  224 
Bilirubin is involved in haemoglobin and prophyrin metabolism and also acts as an 225 
endogenous anti-oxidant. Reflecting our findings, lower levels of serum bilirubin have been found to 226 
correlate with increased abdominal adiposity and metabolic complications
35-37
. Higher intakes of fried 227 
and fast foods were significantly associated with lower bilirubin (Z,Z). Higher intakes of total fatty 228 
acids have previously been associated with lower serum bilirubin
37
, whichmay be related to increased 229 
oxidative stress depleting bilirubin levels. Vegetable oil frying reduces oil polyphenols and when fed 230 
to mice increases liver microsomal lipid peroxides
38
.  231 
Hippurate appeared to be the most important metabolite linking diet to VFM. Hippurate is a 232 
mammalian-microbial co-metabolite which is a glycine conjugate of benzoic acid formed in the 233 
mitochondria of the liver
39
 and kidneys
40
, as well as through gut bacterial production of benzoic acid 234 
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from dietary components, primarily polyphenols
41, 42
. Similarly, we found hippurate to be associated 235 
with increased intakes of fruit and wholegrain products. Studies which measured urinary or serum 236 
levels of hippurate in the context of obesity or metabolic diseases have mainly been limited to animal 237 
models which have shown reduced urinary hippuric acid excretion in obesity
43-45
 and elevated levels 238 
in Type II diabetes
46
 compared to controls. We found increased hippurate in blood to be associated 239 
with elevated adipose tissue expression of neuroglobin, a type of globin primarily expressed in 240 
neurons and some endocrine tissues
47
 which protects cells against hypoxia and oxidative stress
48
. 241 
Neurglobin expression in adipose tissue has not been studied extensively. Though the process of 242 
hypoxia has recently emerged within the literature as a potential mechanism in the development of 243 
adipose tissue dysfunction
49
. This highlights a potential means by which hippurate may protect against 244 
adipose tissue dysfunction and VFM development as a result.  245 
The species E. dolichum within the family Erysipelotrichaceae was positively associated with 246 
the dietary VFM score and VFM, suggesting a role of this microbe in VFM development modulated 247 
by diet (in particular whole grain consumption). In a mouse model of Western-style diet induced 248 
obesity, E. dolichum was found to be elevated
50
, moreover metagenomics analysis demonstrated the 249 
E. dolichum genome to be enriched for phosphotransferase proteins with functions in the import and 250 
processing of simple sugars. In another study of two Japanese quail strains (atherosclerotic-resistant 251 
and non) E. dolichum was overabundant when atherosclerotic-resistant quails were fed a high 252 
cholesterol diet compared to control
51
. We believe we are the first to identify a link between this 253 
species and a high fat, low fibre diet in human subjects though no literature exists as to the metabolic 254 
implications of this species. It is possible the association between E. dolichum and VFM may 255 
primarily be an artefact of poor diet rather than a factor contributing to VFM, though the association 256 
did remain significant when adjusting for the VFM dietary risk score. The relationship between E. 257 
dolichum and hippurate in our dataset is likely complex and it is beyond the capacity of our dataset to 258 
be adequately explored.  259 
Our study had a number of strengths. We believe we are the first large-scale study to use 260 
multi-omic methods to investigate the impact of diet on VFM. The dietary components of our VFM 261 
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score replicate findings from previous epidemiological studies
1, 3, 5
 justifying the strength/validity of 262 
our score. Like VFM
52
, we found this score to be strongly determined by genetics (h
2
: 44%) which 263 
agrees with previous findings where the heritability of ‘unhealthy’ diet patterns ranged from 33 to 50 264 
%
53
.  The limitations of our study also warrant discussion. Firstly, our population was predominantly 265 
female and therefore, our results may not apply to men. As our study is cross sectional it does not 266 
allow us to attribute cause and effect to our findings. Although we adjusted for possible confounders 267 
there is still the possibility of residual or unmeasured confounding from additional unmeasured factors 268 
or measurement error. However given our detailed adjustment for a comprehensive set of confounders 269 
and adjustment for multiple testing it is unlikely that these would account fully for the observed 270 
results. Our characterisation of the gut microbiome was also limited by the use of 16S gene 271 
sequencing. Further investigation using metagenomic approaches might provide a deeper 272 
understanding of the microbe-metabolite interactions at a functional level. Different time points were 273 
used for different samples, though likely our results would improve if the same time point was used. 274 
We did not have repeated measurements for subjects and could therefore not examine intra-individual 275 
variation. We did not replicate our findings in an independent population, though we were able to 276 
replicate the associations between VFM and the diet score, hippurate and butyrlcarnitine in MZ twins 277 
discordant for VFM, who are matched for age, gender and the baseline genetic sequence.  278 
Conclusions 279 
An unhealthy dietary pattern is a strong determinant of VFM. Using this unique dataset we linked a 280 
dietary VFM score and VFM to a gut microbial species and metabolites in the blood. Specifically, in 281 
our population the species E. dolichum appears to link the intake of a diet low in fruit, whole grains 282 
and fermented dairy products and high in red, processed meat and eggs and fried and fast foods to 283 
VFM. Moreover, we identified hippurate, a microbial metabolite involved in benzoate metabolism, to 284 
link these components to the microbiome. Hippurate was in turn associated with adipose expression of 285 
neuroglobin, suggesting a plausible mechanism of interaction. Future studies should aim to confirm 286 
these results in a dietary intervention setting and explore the health implications of our findings.  287 
 288 
 289 
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Figure 1: Outline of the study design 
Figure 2: Receiver operating characteristic curve for the VFM diet score ability to predict the 
bottom and top tertiles of VFM 
Figure 3: Nutrient profile of the VFM diet score presented as percentages of the UK dietary 
reference values by tertile of the VFM diet score.  
Average nutrient intakes by increasing tertile of the VFM diet score from clockwise (lightest to 
darkest) were assessed for percentage of the recommended intakes for 55-year-old women (according 
to the UK Dietary Reference Values 
54
). Using VFM diet score by tertile as the predictor of the 
residual energy adjusted nutrient intakes in a linear regression statistically significant trends (p < 
0.001) were observed for all nutrients, except polyunsaturated fatty acids, protein, zinc and vitamin D. 
Carotene and retinol are represented as percentage of the recommended intake for total retinol 
equivalents. There is no UK DRV for vitamin D therefore 10 ug/d was used. Abbreviations: SFAs, 
saturated fatty acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; 
Trans, trans fatty acids; CHO, carbohydrates; NSP, non-starch polysaccharides; vit, vitamin. 
 
Legend to Fig. 4: Comparisons of the VFM diet score, alpha diversity and top microbiome and 
metabolite associations in the low and high MZ VFM-discordant twins.  
All variables were standardized to have mean=0, SD=1. A linear regression was conducted using the 
VFM diet score, alpha diversity (Shannon Index) and top microbiome and metabolite associations to 
predict VFM in the MZ discordant (1 SD apart in VFM) twin sample.  Significantly (P<0.05) higher 
VFM diet scores and butyrylcarnitine, and lower hippurate were observed with increasing VFM (*).  
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Table 1. List of metabolites independently associated with the VFM diet score (P<0.01 in backward linear regression), their association with VFM and the 
proportion of the association of the VFM diet score with VFM that is mediated by the VFM diet score association with the metabolites (P<5.56x10
-3
). 
NS= not significant: P>0.05 
(1) Thirty metabolites significantly associated with the VFM diet score (Table 2) were adjusted for covariates (batch effects, age, BMI and sex) and fitted into a 
backward stepwise linear regression to predict the VFM diet score using P<0.01 as the threshold cut-off.  
(2) Nine metabolites independently associated with the VFM diet score were tested for their association with VFM adjusted for covariates (age, batch effects, BMI, total 
fat, sex, height
2
, and family relatedness). Associations passing the Bonferonni cut-off were considered significant (P<5.56x10
-3
).  
(3) the proportion of the variance in VFM explained by the VFM diet score after taking into account all covariates (age, sex, BMI, height2, and batch effects). 
the proportion of the variance in VFM explained by the VFM diet score after taking into account all covariates as in (1) and adjusting for the metabolite. 
 VFM diet score stepwise (1) VFM (2)    
Metabolite name beta(SE) P beta(SE) P 
diet R2 no metabolite 
(3) 
diet R2 with metabolite 
(4) 
% association through 
metabolite 
Hippurate  -0.45(0.10) 2.15x10-5 -0.081(0.012) 1.33x10-11 0.0312 0.0222 28.8% 
alpha-Hydroxyisovalerate  0.38(0.10) 9.60x10-5  0.050(0.013) 1.65x10-4 
 
0.0270 13.5% 
Butyrylcarnitine   0.33(0.10) 8.54x10-4  0.072(0.013) 5.86x10-8 
 
0.0267 14.4% 
Bilirubin (Z,Z)   -0.31(0.10) 1.76x10-3 -0.049(0.013) 1.88x10-4 
 
0.0258 17.3% 
Indolepropionate  -0.33(0.11) 2.21x10-3 -0.030(0.012) 1.40x10-2 
   
1-Arachidonoylglycerophosphocholine*   0.27(0.10) 5.20x10-3  0.031(0.012) 1.07x10-2 
   
Eicosapentaenoate (EPA; 20:5n3) -0.75(0.10) 1.13x10-13  0.020(0.012) NS 
   
Threonate  -0.32(0.11) 2.59x10-3 -0.016(0.012) NS 
   
X-11793--Oxidized bilirubin*  0.33(0.11) 2.63x10-3 -0.004(0.012) NS 
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Table 2. List of taxa associated with the VFM diet score (unadjusted and adjusted for other food 
intakes), their association with foods forming the VFM diet score and their independent association 
with the VFM diet score (P<0.05 in backward linear regression). 
  VFM Score (1) VFM Score adjusted foods (2) Foods associated (3) 
Taxon Level beta(SE) P beta(SE) P P<0.05 
Actinomyces genus  0.052(0.011) 9.77x10-7  0.052(0.011) 9.77x10-7 FF (0.028(0.009))* 
RM (0.027(0.008))* 
Lachnospira genus -0.045(0.009) 2.79x10-6 -0.038(0.010) 8.33x10-5 Fruit (0.006(0.002)) 
Actinomycetaceae family  0.043(0.011) 5.47x10-5  0.043(0.011) 5.47x10-5 FF (0.021(0.010)) 
RM (0.024(0.008)) 
Eubacterium dolichum (4) species  0.042(0.011) 8.47x10-5  0.043(0.011) 6.19x10-5 WG (-0.010(0.004)) 
Veillonella dispar species -0.039(0.011) 3.05x10-4 -0.031(0.011) 4.00x10-3 None 
Anaeroplasmataceae family -0.037(0.010) 3.75x10-4 -0.036(0.010) 3.37x10-4 Fruit (0.007(0.003)) 
WG (0.011(0.004)) 
 *= statistically significant: P<0.0025: FF: Fried and fast foods; RM: Red meat; WG: Wholegrain products 
(1) Taxa associations with the VFM diet score were adjusted for covariates (age, Shannon Index, BMI and 
sex) and multiple testing.  
(2) The VFM diet score and 15 food groups not forming the score were fitted into a backward stepwise 
linear regression model to predict each significant taxon using P<0.05 as the cut off threshold.  
(3) All 20 food groups were fitted into a backward stepwise linear regression model to predict each 
significant taxon using P<0.05 as the cut off threshold. Significant results shown only for foods 
forming the VFM diet score.  
(4) Eubacterium dolichum is the only taxon associated with VFM independently of the VFM diet score 
(Beta[SE]: 0.057[0.019], P=2.74x10
-3
). 
 
©    2017 Macmillan Publishers Limited. All rights reserved.
©    2017 Macmillan Publishers Limited. All rights reserved.
©    2017 Macmillan Publishers Limited. All rights reserved.
©    2017 Macmillan Publishers Limited. All rights reserved.
©    2017 Macmillan Publishers Limited. All rights reserved.
